Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 69097-893

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 69097-893). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Sevelamer Carbonate Tabs 800mg)

Label for Sevelamer Carbonate tablets 800 mg, film-coated, oral dosage form, packaged as 270 tablets. The label includes the product name, strength, quantity, and inactive ingredients. Manufactured for Cipla USA Inc. and produced by InvaGen Pharmaceuticals. Also displayed are storage instructions, barcode, and barcode-related codes.*

FDA Label Image

Chemical Structure/figure 1 (Sevelamer Carbonate Tabs Fig01)

Chemical structure diagram of Sevelamer carbonate showing its polymeric components with ammonium groups, bicarbonate ions, and hydroxyl and amine functional groups.*

FDA Label Image

Figure 2 (Sevelamer Carbonate Tabs Fig02)

A line graph comparing the percentage of patients achieving various levels of reduction in serum phosphorus (mg/dL) between Sevelamer Hydrochloride and an active control. The x-axis represents reduction in serum phosphorus, ranging from worsened increase to improved reduction, while the y-axis shows the percentage of patients with reductions greater than or equal to specific values.*

FDA Label Image

Figure 3 (Sevelamer Carbonate Tabs Fig03)

A line graph showing phosphorus change from baseline over a 52-week study period. The x-axis represents study weeks from 0 to 52, and the y-axis shows phosphorus change ranging from -5 to 2. Two treatment groups are compared: Sevelamer Hydrochloride (black circles) and Active-Control (red squares), with both showing a decrease in phosphorus levels early in the study, then stabilizing over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.